Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis

Gut

Volumn 45, Issue 6, 1999, Pages 895-899

  Chen, C C ^a   Wang, S S ^a   Lu, R H ^a   Chang, F Y ^a   Lee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute pancreatitis; C reactive protein; Interleukin 10; Interleukin 11

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 11;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0032758196     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.6.895     Document Type: Article

References (35)

1. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-12.
2. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines: new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepato-Gastroenterol 1993;40:522-30.
3. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
4. Viedman JA, Pèrez-Mateo M, Dominguez JE, et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
5. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
6. Gross V, Leser HG, Andreesen R, et al. Interleukin-8 (IL-8) and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-3.
7. Exley AR, Leese T, Holloday MP, et al. Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
8. Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-18.
9. Florentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
10. Raphe P, Nakoinz I, Sampson-Johannes A, et al. T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808-14.
11. Willems F, Marchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-I expression on human monocytes. Eur J Immunol 1994;24:1007-9.
12. Taga K, Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
13. Marchant A, Devière J, Byl B, et al. Interleukin-10 production during septicaemia. Lancet 1994;343:707-8.
14. Rongione AJ, Kusske AM, Kwan K, et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-7.
15. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-22.
16. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997;42:1469-72.
17. Wereszczynska-Siemiatkowska U, Dabrowski A, Gabryclewicz A, et al. Serum E-selectin (ES), interleukin-10 (IL-10), interleukin-6 (IL-6) and plasma polymorphonuclear clastase PMN-E in different severity forms of human acute pancreatitis (AP). Digestion 1998;59(suppl 3):484-5.
18. Neben S, Turner K. The biology of interleukin-11. Stem Cells 1993;11(suppl 2):156-62.
19. Yin TG, Schendel P, Yang YC. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin-11. J Exp Med 1992;175:211-16.
20. Baumann H, Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 1991;266:20424-7.
21. Trepicchio WL, Bozza M, Pedneault G, et al. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996;157:3627-34.
22. Lavin M, McMahon MJ. APACHE II score for assessment and monitoring of acute pancreatitis. Lancet 1989;ii:201-5.
23. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-4.
24. Ranson JHC, Pasternak BS. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 1977;22:79-91.
25. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993;129:586-90.
26. Harmoinen A, Perko M, Gronroos P. Rapid quantitative determination of C-reactive protein using LKB 8600 reaction rate analyzer. Clin Chim Acta 1981;111:117-20.
27. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-30.
28. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-30.
29. Oezcueruemez-Porsch M, Kunz D, Hardt PD, et al. Diagnostic relevance on interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998;43:1763-9.
30. van Deuren M, van der Ven-Jongekrijg J, Bartelink AKM, et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995;172:433-9.
31. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
32. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289-97.
33. Van Laethern JL, Eskinazi R, Louis H, et al. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998;43:408-13.
34. Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989;242:237-9.
35. Gabay C, Singwe M, Genin B, et al. Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver. Clin Exp Immunol 1996;105:260-5.